Posted On: 11/22/2015 12:57:11 PM
Post# of 72441
This was shared by "NYC Purple" on the other board. It seems like Kevetrin's potential is being recognized by MD Anderson but they didn't mention it by name so can't be 100% sure.
This preclinical research shows an experimental drug currently in phase I clinical trials can replace the immunity-protecting role lost when p53 fails.
http://www.news-medical.net/news/20151121/Cru...ancer.aspx
This preclinical research shows an experimental drug currently in phase I clinical trials can replace the immunity-protecting role lost when p53 fails.
http://www.news-medical.net/news/20151121/Cru...ancer.aspx
(0)
(0)
***On 02/26/2016 at 8:33 am Scottsmith admited to posting under 5 aliases but his post was subsequently deleted. I have a screen shot and will email it to anyone interested.
Scroll down for more posts ▼
